SYRE — SPYRE THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in SPYRE THERAPEUTICS INC (SYRE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 20,232 -9,814 -32.7% 0.00% $339K $16.76
2025 Q2 REDUCED 30,046 -41,965 -58.3% 0.00% $450K $14.97
2025 Q1 ADDED 72,011 +56,780 +372.8% 0.00% $1.2M $16.14
2024 Q4 ADDED 15,231 +6,754 +79.7% 0.00% $355K $23.28
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SYRE price (monthly, adj. close)

Other funds also holding SYRE

As of 2025 Q4 — sorted by position size

Remedium Capital Partners, LLC 28.03% Fairmount Funds Management LLC 3Y 10.02% CAXTON CORP 3Y 7Y 6.83% VR Adviser, LLC 3Y 5.96% Commodore Capital LP 3Y 5.21% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 3.06% Affinity Asset Advisors, LLC 3Y 2.67% B Group, Inc. 2.42% TCG Crossover Management, LLC 3Y 2.06% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.79%
← Back to Squarepoint Ops LLC Holdings